Yield10 Bioscience, Inc. Announces Executive Changes
February 13, 2020 at 11:40 am EST
Share
On February 11, 2020, the Board of Directors (the Board") of Yield10 Bioscience, Inc. (the Company") appointed Sherri M. Brown, Ph.D., effective immediately, as a member of the Board, to serve as a Class I Director with a term expiring at the Company's 2022 annual meeting of stockholders. In connection with her appointment, Dr. Brown was appointed to serve as chair of a newly formed Technology Committee of the Board. Dr. Brown has been Managing Director at the Yield Lab since 2017. On February 11, 2020, Peter Kellogg resigned from the Board effective immediately. His resignation was not the result of any disagreement with the Company relating to the Company's policies or practices. Effective February 11, 2020, Anthony Sinskey was appointed to serve as a member of the Audit Committee of the Board.
Yield10 Bioscience, Inc. is an agricultural bioscience company. The Company is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. It is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. It is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The Company's development pipeline falls into three categories: input traits, performance traits and new seed product traits.
YIELD10 BIOSCIENCE, INC. 
